Scottish Biotech Firm Secures £2m to Pioneer Blood Disease Treatment

A Scottish biotech company has secured £2 million as part of a funding round led by Kelvin Capital and the Scottish Investment Bank. ProFactor Pharma (PFP), based at the Roslin Innovation Centre just outside Edinburgh, will use the funding boost to further develop its pioneering treatment for ‘Haemophilia A’ blood disease. The funding will also … Continue reading Scottish Biotech Firm Secures £2m to Pioneer Blood Disease Treatment